April 2025
1. YOUNOSSI ZM, Zelber-Sagi S, Lazarus JV, Wai-Sun Wong V, et al
   Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis.
   Gastroenterology. 2025 Apr 11:S0016-5085(25)00632.
   

   >> Share

   
   
2. GUPTA V, Sehrawat TS, Pinzani M, Strazzabosco M, et al
   Portal Fibrosis and the Ductular Reaction: Pathophysiological Role in the Progression of Liver Disease and Translational Opportunities.
   Gastroenterology. 2025;168:675-690.
   

   >> Share

   
   March 2025
3. SILVEY S, Patel N, Khoruts A, Bajaj JS, et al
   Rifaximin does not increase the rate of 30-day mortality in patients with cirrhosis and daptomycin in two National US-based cohorts.
   Gastroenterology. 2025 Mar 21:S0016-5085(25)00535.
   

   >> Share

   
   
4. KISSELEVA T, Ganguly S, Murad R, Wang A, et al
   Regulation of Hepatic Stellate Cell Phenotypes in MASH.
   Gastroenterology. 2025 Mar 20:S0016-5085(25)00528.
   

   >> Share

   
   February 2025
5. PAN S, Chen J, Li X
   An Unusual Case of Unexplained Portal Hypertension and Splenomegaly.
   Gastroenterology. 2025 Feb 18:S0016-5085(25)00374.
   

   >> Share

   
   
6. PEERY AF, Murphy CC, Anderson C, Jensen ET, et al
   Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2024.
   Gastroenterology. 2025 Feb 4:S0016-5085(25)00034.
   

   >> Share

   
   
7. FROMME M, Payance A, Mandorfer M, Thorhauge KH, et al
   Longitudinal Evaluation of Individuals With Severe Alpha-1 Antitrypsin Deficiency (Pi *ZZ Genotype).
   Gastroenterology. 2025;168:367-381.
   

   >> Share

   
   January 2025
8. KUMAR N, Chaudhary A
   Comments on "Recompensation of Chronic Hepatitis C-Related Decompensated Cirrhosis Following Direct-Acting Antiviral Therapy: Prospective Cohort Study From a Hepatitis C Virus Elimination Program".
   Gastroenterology. 2025 Jan 30:S0016-5085(25)00326.
   

   >> Share

   
   
9. KRONSTEN VT, Paintsil EK, Rodrigues S, Seager MJ, et al
   Hepatic encephalopathy - when lactulose and rifaximin are not working.
   Gastroenterology. 2025 Jan 24:S0016-5085(25)00050.
   

   >> Share

   
   
10. RHEE H, Kim MJ, Kim DY, An C, et al
    Non-contrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance: A randomized, single-center trial.
    Gastroenterology. 2025 Jan 22:S0016-5085(25)00049.
    

    >> Share

    
    December 2024
11. DAVIS JPE, Lim JK, Francis FF, Ahn J, et al
    AGA Clinical Practice Update on Management of Portal Vein Thrombosis in Patients With Cirrhosis: Expert Review.
    Gastroenterology. 2024 Dec 20:S0016-5085(24)05664.
    

    >> Share

    
    November 2024
12. NORMAN J, Mehta N, Kim WR, Liang JW, et al
    Multi-HCC: A practical model to prioritize patients with hepatocellular carcinoma on the liver transplant waiting list.
    Gastroenterology. 2024 Nov 30:S0016-5085(24)05754.
    

    >> Share

    
    
13. MEZZACAPPA C
    Gastro Digest: The Revised REACH-B Model Predicts Hepatocellular Carcinoma in Patients with Chronic Hepatitis B.
    Gastroenterology. 2024 Nov 30:S0016-5085(24)05756.
    

    >> Share

    
    
14. MULLISH BH
    New agonists of the incretin/glucagon system for the treatment of metabolic dysfunction-associated steatohepatitis.
    Gastroenterology. 2024 Nov 30:S0016-5085(24)05755.
    

    >> Share

    
    
15. FOERSTER F, Galle PR
    To Look or Not to Look: A New Score for Stratifying Patients at Risk of Developing Hepatocellular Carcinoma.
    Gastroenterology. 2024 Nov 30:S0016-5085(24)05753.
    

    >> Share

    
    
16. ELLER M, Westbrook L, Kalra A
    Expanding the Differential Diagnosis: Severe, Swollen Hepatocytes in a Patient with an ALT above 1000 U/L.
    Gastroenterology. 2024 Nov 16:S0016-5085(24)05697.
    

    >> Share

    
    
17. FUJIWARA N, Lopez C, Marsh TL, Raman I, et al
    Phase 3 validation of PAaM for hepatocellular carcinoma risk stratification in cirrhosis.
    Gastroenterology. 2024 Nov 7:S0016-5085(24)05660.
    

    >> Share

    
    
18. DE ALMEIDA SOUZA GL, Chebli VA, Fonseca Chebli JM
    An intriguing case of hepatosplenic lesions and pneumonia during anti-TNF therapy for IBD.
    Gastroenterology. 2024 Nov 6:S0016-5085(24)05661.
    

    >> Share

    
    
19. DORNER H, Stolzer I, Mattner J, Kaminski S, et al
    Gut Pathobiont-Derived Outer Membrane Vesicles Drive Liver Inflammation and Fibrosis in Primary Sclerosing Cholangitis-Associated Inflammatory Bowel Disease.
    Gastroenterology. 2024;167:1183-1197.
    

    >> Share

    
    October 2024
20. WANG Z, Li J, Li Y
    Insights into the protective role of GLP-1RAs in the treatment of type 2 diabetes mellitus: implications for hepatocellular carcinoma and hepatic dysfunction.
    Gastroenterology. 2024 Oct 17:S0016-5085(24)05578.
    

    >> Share

    
    
21. WEI JC, Wu CN, Cheng WC
    Comments on "Association of GLP-1 Receptor Agonists and Hepatocellular Carcinoma Incidence and Hepatic Decompensation in Patients With Type 2 Diabetes".
    Gastroenterology. 2024 Oct 17:S0016-5085(24)05581.
    

    >> Share

    
    
22. WEI JC, Kuo P, Mei Q
    Methodology of Study on GLP-1 Receptor Agonists and Hepatocellular Carcinoma Risk.
    Gastroenterology. 2024 Oct 17:S0016-5085(24)05579.
    

    >> Share

    
    
23. LIU Z, Shan D, Han X
    GLP-1 Receptor Agonists' Role in Reducing Hepatocellular Carcinoma Risk.
    Gastroenterology. 2024 Oct 16:S0016-5085(24)05580.
    

    >> Share

    
    
24. RATHORE M, Curry K, Huang W, Wright M, et al
    LRG1 promotes metastatic colorectal cancer growth through HER3 signaling.
    Gastroenterology. 2024 Oct 9:S0016-5085(24)05566.
    

    >> Share

    
    
25. KOTHARI S, Afshar Y, Friedman LS, Ahn J, et al
    AGA Clinical Practice Update on Pregnancy-Related Gastrointestinal and Liver Disease: Expert Review.
    Gastroenterology. 2024;167:1033-1045.
    

    >> Share

    
    
26. HUPERTZ VF
    A Further Step Toward Possible Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease.
    Gastroenterology. 2024;167:847-848.
    

    >> Share

    
    
27. CLARK VC, Strange C, Strnad P, Sanchez AJ, et al
    Fazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA).
    Gastroenterology. 2024;167:1008-1018.
    

    >> Share

    
    
28. ALLEGRETTI JR, Khanna S, Mullish BH, Feuerstadt P, et al
    The Progression of Microbiome Therapeutics for the Management of Gastrointestinal Diseases and Beyond.
    Gastroenterology. 2024;167:885-902.
    

    >> Share

    
    September 2024
29. MAK LY, Yuen MF
    Surveillance for hepatocellular carcinoma in cirrhosis: End of monopoly for serum alpha fetoprotein.
    Gastroenterology. 2024 Sep 28:S0016-5085(24)05533.
    

    >> Share

    
    
30. MARSH TL, Parikh ND, Roberts LR, Schwartz ME, et al
    A Phase 3 Biomarker Validation of GALAD for the Detection of Hepatocellular Carcinoma in Cirrhosis.
    Gastroenterology. 2024 Sep 16:S0016-5085(24)05460.
    

    >> Share

    
    
31. GINES P, Serra-Burriel M
    Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Steatotic Liver Disease in Patients With Type 2 Diabetes Mellitus: Growing Evidence But Not Yet There.
    Gastroenterology. 2024;167:653-655.
    

    >> Share

    
    
32. ASOMBANG AW, Mohamed MF, Egboh SC, Omede M, et al
    The Importance of Global Health Training in US-Based Gastroenterology and Hepatology Fellowship Programs.
    Gastroenterology. 2024;167:643-648.
    

    >> Share

    
    August 2024
33. PREMKUMAR M, Dhiman RK, Duseja A, Mehtani R, et al
    Recompensation of Chronic Hepatitis C-related decompensated cirrhosis following direct-acting antiviral therapy: Prospective Cohort study from an HCV elimination program.
    Gastroenterology. 2024 Aug 22:S0016-5085(24)05359.
    

    >> Share

    
    
34. GIBBENS Y, Lake J, Lim N
    A Rare Cause of Acute Liver Failure.
    Gastroenterology. 2024;167:446-449.
    

    >> Share

    
    
35. CHENG X, Dai E, Wu J, Flores NM, et al
    Atlas of metastatic gastric cancer links ferroptosis to disease progression and immunotherapy response.
    Gastroenterology. 2024 Aug 1:S0016-5085(24)05297.
    

    >> Share

    
    July 2024
36. VAN KLEEF LA, Francque SM, Prieto-Ortiz JE, Sonneveld MJ, et al
    Metabolic Dysfunction-Associated Fibrosis 5 (MAF-5) Score Predicts Liver Fibrosis Risk and Outcome in the General Population With Metabolic Dysfunction.
    Gastroenterology. 2024;167:357-367.
    

    >> Share

    
    
37. NAIMIMOHASSES S, Bhat M
    Novel Multimodal Database for Metabolic Dysfunction-Associated Steatotic Liver Disease-Linking Genes to Outcomes.
    Gastroenterology. 2024;167:410-411.
    

    >> Share

    
    
38. SUI B, Wang R, Chen C, Kou X, et al
    Apoptotic Vesicular Metabolism Contributes to Organelle Assembly and Safeguards Liver Homeostasis and Regeneration.
    Gastroenterology. 2024;167:343-356.
    

    >> Share

    
    June 2024
39. ZENG T, Xiong J, Li X
    A rare cause of hepatic mass with high metabolic activity and jaundice.
    Gastroenterology. 2024 Jun 29:S0016-5085(24)05173.
    

    >> Share

    
    
40. SUTTON H, Bhat M
    Novel migratory hepatocyte population contributes to liver regeneration in acute liver injury.
    Gastroenterology. 2024 Jun 27:S0016-5085(24)05176.
    

    >> Share

    
    
41. KO S, Monga SP
    The dark side of human hepatocyte plasticity.
    Gastroenterology. 2024 Jun 25:S0016-5085(24)05116.
    

    >> Share

    
    
42. LENS S
    Resmetirom for Non-alcoholic Steatohepatitis.
    Gastroenterology. 2024 Jun 25:S0016-5085(24)05120.
    

    >> Share

    
    
43. VENKATESWARAN N
    Seladelpar as an alternate second line agent for Primary Biliary Cirrhosis.
    Gastroenterology. 2024 Jun 20:S0016-5085(24)05064.
    

    >> Share

    
    
44. ZHU CP, Liu SQ, Wang KQ, Xiong HL, et al
    Targeting 5-Hydroxytryptamine receptor 1A in portal vein to decrease portal hypertension.
    Gastroenterology. 2024 Jun 19:S0016-5085(24)05062.
    

    >> Share

    
    
45. HSU BY, Driscoll J, Tateno C, Mattis AN, et al
    Human Hepatocytes Can Give Rise To Intrahepatic Cholangiocarcinomas.
    Gastroenterology. 2024 Jun 10:S0016-5085(24)05028.
    

    >> Share

    
    
46. LEE BP, Louvet A
    Longitudinal Change of Alcohol Use is a Dynamic Contributor to Steatotic Liver Disease Progression.
    Gastroenterology. 2024;166:965-967.
    

    >> Share

    
    
47. LO GH
    The Optimal Duration of Vasoconstrictors for Acute Variceal Hemorrhage: Longer Is Safer?
    Gastroenterology. 2024;166:1197-1198.
    

    >> Share

    
    
48. WANG H, Yuan S, Zheng Q, Zhang S, et al
    Dual Inhibition of CDK4/6 and XPO1 Induces Senescence With Acquired Vulnerability to CRBN-Based PROTAC Drugs.
    Gastroenterology. 2024;166:1130-1144.
    

    >> Share

    
    May 2024
49. HANSCOM M
    Magnetically guided capsule endoscopy comparable to EGD for detecting esophagogastric varices in patients with cirrhosis.
    Gastroenterology. 2024 May 28:S0016-5085(24)05001.
    

    >> Share

    
    
50. WANG R, Li B, Huang B, Li Y, et al
    Gut microbiota-derived butyrate induces epigenetic and metabolic reprogramming in myeloid-derived suppressor cells to alleviate primary biliary cholangitis.
    Gastroenterology. 2024 May 27:S0016-5085(24)04936.
    

    >> Share

    
    
51. HILSCHER MB, Wysokinski WE, Andrews JC, Simonetto DA, et al
    Portal Vein Thrombosis in the Setting of Cirrhosis: Evaluation and Management Strategies.
    Gastroenterology. 2024 May 25:S0016-5085(24)04951.
    

    >> Share

    
    
52. CHANG M, Hammami MB, Sakiani S
    A Case of Hepatobiliary Challenges: Unraveling the Mystery of Bile Duct Disappearance.
    Gastroenterology. 2024 May 14:S0016-5085(24)04914.
    

    >> Share

    
    
53. NIEMI NM, Debosch BJ
    Survival of the Fittest: Clonal Selection of Somatic Mutations Reveals Targets to Abate Chronic Liver Injury.
    Gastroenterology. 2024;166:936-937.
    

    >> Share

    
    
54. GEORGE B, Kudryashova O, Kravets A, Thalji S, et al
    Transcriptomic-Based Microenvironment Classification Reveals Precision Medicine Strategies for Pancreatic Ductal Adenocarcinoma.
    Gastroenterology. 2024;166:859-871.
    

    >> Share

    
    
55. SCHONAUER R, Sierks D, Boerrigter M, Jawaid T, et al
    Sex, Genotype, and Liver Volume Progression as Risk of Hospitalization Determinants in Autosomal Dominant Polycystic Liver Disease.
    Gastroenterology. 2024;166:902-914.
    

    >> Share

    
    April 2024
56. WANG L, Berger NA, Kaelber DC, Xu R, et al
    Association of GLP-1 receptor agonists and hepatocellular carcinoma incidence and hepatic decompensation in patients with type 2 diabetes.
    Gastroenterology. 2024 Apr 29:S0016-5085(24)00494.
    

    >> Share

    
    
57. JIANG C, Lian M, Ma X
    A Rare Case Mimicking Congenital Hepatic Fibrosis.
    Gastroenterology. 2024 Apr 23:S0016-5085(24)00483.
    

    >> Share

    
    March 2024
58. CAMPANI C, Guido M, Marra F
    Elusive hepatic nodules.
    Gastroenterology. 2024 Mar 23:S0016-5085(24)00355.
    

    >> Share

    
    
59. HOLTZ LR, DeBosch BJ
    Deploying Lactulose as a Prebiotic to Reduce Complications of Chronic Liver Disease.
    Gastroenterology. 2024;166:534-535.
    

    >> Share

    
    
60. URIAS E, Tedesco NR, Oliveri A, Raut C, et al
    PNPLA3 Risk Allele Association With ALT Response to Semaglutide Treatment.
    Gastroenterology. 2024;166:515-517.
    

    >> Share

    
    
61. GAO F, Seto WK, Zheng MH
    Preventing Overdiagnosis of Nonalcoholic Fatty Liver Disease: Established Cutoff Values for Transient Elastography Are Needed.
    Gastroenterology. 2024;166:541-542.
    

    >> Share

    
    
62. AN T, Liu L, Li X
    Factors Associated With the Influence of Liver Fibrosis Should Be Fully Considered.
    Gastroenterology. 2024;166:540-541.
    

    >> Share

    
    February 2024
63. WONG RJ, Yang Z, Cheung R, Singal AK, et al
    Impact of Longitudinal Alcohol Use Patterns on Long-Term Risk of Cirrhosis Among U.S. Veterans with Steatotic Liver Disease.
    Gastroenterology. 2024 Feb 28:S0016-5085(24)00238.
    

    >> Share

    
    
64. CHEN J, Feng W, Sun M, Huang W, et al
    TGF-beta1 Induced SOX18 Elevation Promotes Hepatocellular Carcinoma Progression and Metastasis through Transcriptionally Upregulating PD-L1 and CXCL12.
    Gastroenterology. 2024 Feb 26:S0016-5085(24)00187.
    

    >> Share

    
    
65. LENS S
    In Search of the Best Second-Line Therapy for Primary Biliary Cholangitis.
    Gastroenterology. 2024 Feb 20:S0016-5085(24)00185.
    

    >> Share

    
    
66. HERMS Q, Fuster-Anglada C, Juanola A
    Pembrolizumab-induced Liver Injury: Beyond Immune-Mediated Hepatitis.
    Gastroenterology. 2024 Feb 4:S0016-5085(24)00133.
    

    >> Share

    
    
67. ALLEN AM, Pose E, Reddy KR, Russo MW, et al
    Nonalcoholic Fatty Liver Disease Gets Renamed as Metabolic Dysfunction-Associated Steatotic Liver Disease: Progress But With Challenges.
    Gastroenterology. 2024;166:229-234.
    

    >> Share

    
    
68. WALAYAT S, Pfau P
    2 AM in the Intensive Care Unit: What Could Go Wrong?
    Gastroenterology. 2024;166:e13-e15.
    

    >> Share

    
    
69. BILAL M, Steinberg J, Louissaint J, Phan J, et al
    First Year on the Job as a Gastroenterologist and Hepatologist: Lessons Learned.
    Gastroenterology. 2024 Feb 1:S0016-5085(24)00125.
    

    >> Share

    
    January 2024
70. POSE E, Piano S, Juanola A, Gines P, et al
    HEPATORENAL SYNDROME IN CIRRHOSIS.
    Gastroenterology. 2024 Jan 19:S0016-5085(24)00054.
    

    >> Share

    
    
71. LAURIDSEN MM, Gronkjaer LL, Khraibut S, Patel N, et al
    The multi-dimensional challenge of poor oral health in cirrhosis - disparities and solutions.
    Gastroenterology. 2024 Jan 13:S0016-5085(24)00043.
    

    >> Share

    
    
72. MULLISH BH
    Risk Factors for Liver Cancer and Chronic Liver Disease-related Death: Are Sugar Substitutes Better Than the Real Thing?
    Gastroenterology. 2024;166:213-214.
    

    >> Share

    
    
73. ZENG Q, Wu D, Tang H
    A Mysterious Abdominal Pain.
    Gastroenterology. 2024;166:27-30.
    

    >> Share

    
    December 2023
74. MEZZACAPPA C, Bhat M
    Proteomic Panels for Alcohol-Associated Liver Disease: Accurate, but Different Enough From Existing Clinical Tests?
    Gastroenterology. 2023;165:1576.
    

    >> Share

    
    November 2023
75. GARCIA-TSAO G, Abraldes JG, Rich NE, Wong VW, et al
    AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review.
    Gastroenterology. 2023 Nov 17:S0016-5085(23)05143.
    

    >> Share

    
    
76. KOJIMA H, Kadono K, Hirao H, Dery KJ, et al
    T Cell CEACAM1-TIM-3 Crosstalk Alleviates Liver Transplant Injury in Mice and Humans.
    Gastroenterology. 2023;165:1233-1248.
    

    >> Share

    
    
77. PENA-SANCHEZ JN, Osei JA, Teucher U, Tremblay M, et al
    Working With Indigenous Community and Patient Partners Is Essential to Advance Gastroenterology and Hepatology Research: Perspectives From Canada.
    Gastroenterology. 2023;165:1097-1101.
    

    >> Share

    
    
78. LLOVET JM, Heikenwalder M
    Atezolizumab Plus Bevacizumab in Advanced HCC: Efficacy in NASH-Specific Etiology.
    Gastroenterology. 2023;165:1308-1310.
    

    >> Share

    
    October 2023
79. AMPUERO J, Berzigotti A
    Prognostication in Advanced Chronic Liver Disease Using Liver Stiffness Measurement: Repetita Iuvant.
    Gastroenterology. 2023;165:829-831.
    

    >> Share

    
    
80. SEMMLER G, Yang Z, Fritz L, Kock F, et al
    Dynamics in Liver Stiffness Measurements Predict Outcomes in Advanced Chronic Liver Disease.
    Gastroenterology. 2023;165:1041-1052.
    

    >> Share

    
    
81. MAN S, Deng Y, Ma Y, Fu J, et al
    Prevalence of Liver Steatosis and Fibrosis in the General Population and Various High-Risk Populations: A Nationwide Study With 5.7 Million Adults in China.
    Gastroenterology. 2023;165:1025-1040.
    

    >> Share

    
    
82. YIP TC, Fan JG, Wong VW
    China's Fatty Liver Crisis: A Looming Public Health Emergency.
    Gastroenterology. 2023;165:825-827.
    

    >> Share

    
    
83. TICA S, Debosch BJ
    Bariatric Surgery for the Treatment of NASH-An Old Solution to a Newer Problem?
    Gastroenterology. 2023;165:1091.
    

    >> Share

    
    
84. WATTACHERIL JJ, Abdelmalek MF, Lim JK, Sanyal AJ, et al
    AGA Clinical Practice Update on the Role of Noninvasive Biomarkers in the Evaluation and Management of Nonalcoholic Fatty Liver Disease: Expert Review.
    Gastroenterology. 2023;165:1080-1088.
    

    >> Share

    
    September 2023
85. CHEN J, Yang Q, Wang C
    Multiple Hepatic Masses in a Patient with Crohn's disease.
    Gastroenterology. 2023 Sep 20:S0016-5085(23)05014.
    

    >> Share

    
    
86. XIE L, Guo H
    Question on the use of BMI >/= 25 kg/m(2) to define obesity to analyze the incidence and risk factors of hepatic steatosis and hepatic fibrosis in the Chinese population.
    Gastroenterology. 2023 Sep 8:S0016-5085(23)04983.
    

    >> Share

    
    
87. MEZZACAPPA C
    Survival in unresectable hepatocellular carcinoma treated with a new immune checkpoint and anti-angiogenic drug combination.
    Gastroenterology. 2023 Sep 6:S0016-5085(23)04976.
    

    >> Share

    
    August 2023
88. SHEN C, Zhang J, Xia Q
    Unexpected Abdominal Wall Varices After Split-Liver Transplantation.
    Gastroenterology. 2023;165:354-356.
    

    >> Share

    
    March 2023
89. GADIYARAM S, Nachiappan M, Kini D
    Liver SOL in a case of colon cancer, a red herring.
    Gastroenterology. 2023 Mar 24:S0016-5085(23)00534.
    

    >> Share

    
    
90. KO PH, Tseng CW
    An Unusual Cause of Acute Cholecystitis.
    Gastroenterology. 2023 Mar 23:S0016-5085(23)00531.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share